527
Views
39
CrossRef citations to date
0
Altmetric
Review

An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II

, , , , &
Pages 567-582 | Received 11 Feb 2019, Accepted 01 May 2019, Published online: 14 May 2019

References

  • Repka MA, Bandari S, Kallakunta VR, et al. Melt extrusion with poorly soluble drugs–an integrated review. Int J Pharm. 2018;535(1–2):68–85.
  • Tiwari RV, Patil H, Repka MA. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opin Drug Deliv. 2016;13(3):451–464.
  • Censi R, Gigliobianco M, Casadidio C, et al. Hot melt extrusion: highlighting physicochemical factors to be investigated while designing and optimizing a hot melt extrusion process. Pharmaceutics. 2018;10(3):89.
  • Crowley MM, Zhang F, Repka MA, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm. 2007;33(9):909–926.
  • Douroumis D, Ross SA, Nokhodchi A. Advanced methodologies for cocrystal synthesis. Adv Drug Deliv Rev. 2017;117:178–195.
  • Kallakunta VR, Tiwari R, Sarabu S, et al. Effect of formulation and process variables on lipid based sustained release tablets via continuous twin screw granulation: A comparative study. Eur J Pharm Sci. 2018;121:126–138.
  • Bhagurkar AM, Angamuthu M, Patil H, et al. Development of an ointment formulation using hot-melt extrusion technology. AAPS PharmSciTech. 2016;17(1):158–166.
  • Vynckier AK, Voorspoels J, Remon JP, et al. Co‐extrusion as a processing technique to manufacture a dual sustained release fixed‐dose combination product. J Pharm Pharmacol. 2016;68(5):721–727.
  • Wening K, Schwier S, Hans-J Stahlberg M, et al. Application of hot-melt extrusion technology in immediate-release abuse-deterrent formulations. J Opioid Manag. 2017;13(6):473–484.
  • Silva LAD, Almeida SL, Alonso EC, et al. Preparation of a solid self-microemulsifying drug delivery system by hot-melt extrusion. Int J Pharm. 2018;541(1–2):1–10.
  • Dumpa NR, Sarabu S, Bandari S, et al. Chronotherapeutic drug delivery of ketoprofen and ibuprofen for improved treatment of early morning stiffness in arthritis using hot-melt extrusion technology. AAPS PharmSciTech. 2018;19(6):2700–2709.
  • Vo AQ, Feng X, Morott JT, et al. A novel floating controlled release drug delivery system prepared by hot-melt extrusion. Eur J Pharm Biopharm. 2016;98:108–121.
  • Melocchi A, Parietti F, Maroni A, et al. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int J Pharm. 2016;509(1–2):255–263.
  • Nasr M, Karandikar H, Abdel-Aziz RT, et al. Novel nicotinamide skin-adhesive hot melt extrudates for treatment of acne. Expert Opin Drug Deliv. 2018;15(12):1165–1173.
  • Berry DJ, Steed JW. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design. Adv Drug Deliv Rev. 2017;117:3–24.
  • Fernandes GJ, Kumar L, Sharma K, et al. A review on solubility enhancement of carvedilol—a BCS class II drug. J Pharm Innov. 2018;13(3):197–212.
  • Karimi-Jafari M, Padrela L, Walker GM, et al. Creating cocrystals: a review of pharmaceutical cocrystal preparation routes and applications. Cryst Growth Des. 2018;18(10):6370–6387.
  • Chavan RB, Thipparaboina R, Kumar D, et al. Co amorphous systems: A product development perspective. Int J Pharm. 2016;515(1–2):403–415.
  • Ross S, Lamprou D, Douroumis D. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies. Chem Comm. 2016;52(57):8772–8786.
  • Chattoraj S, Shi L, Sun CC. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1: 1 co-crystal. CrystEngComm. 2010;12(8):2466–2472.
  • Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009 Jun 3;9(6):2950–2967.
  • Medina C, Daurio D, Nagapudi K, et al. Manufacture of pharmaceutical co‐crystals using twin screw extrusion: A solvent less and scalable process. J Pharm Sci. 2010;99(4):1693–1696.
  • Boksa K, Otte A, Pinal R. Matrix Assisted Cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot melt extrusion. J Pharm Sci. 2014;103(9):2904–2910.
  • Gajda M, Nartowski KP, Pluta J, et al. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal. Eur J Pharm Biopharm. 2018;131:48–59.
  • Li S, Yu T, Tian Y, et al. Mechanochemical synthesis of pharmaceutical cocrystal suspensions via hot melt extrusion: feasibility studies and physicochemical characterization. Mol Pharm. 2016;13(9):3054–3068.
  • Li S, Yu T, Tian Y, et al. Mechanochemical synthesis of pharmaceutical cocrystal suspensions via hot melt extrusion: enhancing cocrystal yield. Mol Pharm. 2018;15(9):3741–3754.
  • Kulkarni C, Wood C, Kelly AL, et al. Stoichiometric control of co-crystal formation by solvent free continuous co-crystallization (SFCC). Cryst Growth Des. 2015;15(12):5648–5651.
  • Moradiya HG, Islam MT, Scoutaris N, et al. Continuous manufacturing of high quality pharmaceutical cocrystals integrated with process analytical tools for in-line process control. Cryst Growth Des. 2016;16(6):3425–3434.
  • Ross SA, Ward A, Basford P, et al. Co–processing of pharmaceutical cocrystals for high quality and enhanced physicochemical stability. Cryst. Growth Des. 2019;19(2):876–888.
  • Fernandes GJ, Rathnanand M, Kulkarni V. Mechanochemical synthesis of carvedilol cocrystals utilizing hot melt extrusion technology. J Pharm Innov. 2018;1–9.
  • Guo Y, Shalaev E, Smith S. Physical stability of pharmaceutical formulations: solid-state characterization of amorphous dispersions. Trends Analyt Chem. 2013;49:137–144.
  • Dengale SJ, Grohganz H, Rades T, et al. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 2016;100:116–125.
  • Arnfast L, Kamruzzaman M, Lobmann K, et al. Melt extrusion of high-dose co-amorphous drug-drug combinations: theme: formulation and manufacturing of solid dosage forms guest editors: Tony Zhou and Tonglei Li. Pharm Res. 2017 Dec;34(12):2689–2697.
  • Lenz E, Lobmann K, Rades T, et al. Hot melt extrusion and spray drying of co-amorphous indomethacin-arginine with polymers. J Pharm Sci. 2017 Jan;106(1):302–312.
  • Suresh K, Mannava MC, Nangia A. A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile. RSC Adv. 2014;4(102):58357–58361.
  • Ford JL, Rubinstein MH. Preparation, properties and ageing of tablets prepared from the chlorpropamide-urea solid dispersion. Int J Pharm. 1981;8(4):311–322.
  • McGinity JW, Maincent P, Steinfink H. Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method. J Pharm Sci. 1984;73(10):1441–1444.
  • Chieng N, Aaltonen J, Saville D, et al. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. Eur J Pharm Biopharm. 2009;71(1):47–54.
  • Arnfast L, Kamruzzaman M, Löbmann K, et al. Melt extrusion of high-dose co-amorphous drug-drug combinations. Pharm Res. 2017;34(12):2689–2697.
  • Mizoguchi R, Waraya H, Hirakura Y. Application of co-amorphous technology for improving the physicochemical properties of amorphous formulations. Mol. Pharm. 2019;16(5):2142–2152.
  • Liu X, Zhou L, Zhang F. Reactive melt extrusion to improve the dissolution performance and physical stability of naproxen amorphous solid dispersions. Mol Pharm. 2017 Mar 6; 14(3):658–673.
  • Lee HL, Vasoya JM, Cirqueira ML, et al. Continuous preparation of 1:1 haloperidol-maleic acid salt by a novel solvent-free method using a twin screw melt extruder. Mol Pharm. 2017 Apr 3;14(4):1278–1291.
  • Bookwala M, Thipsay P, Ross S, et al. Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology. Eur J Pharm Biopharm. 2018;131:109–119.
  • Monteyne T, Vancoillie J, Remon JP, et al. Continuous melt granulation: influence of process and formulation parameters upon granule and tablet properties. Eur J Pharm Biopharm. 2016;107:249–262.
  • Schmidt A, de Waard H, Moll KP, et al. Quantitative assessment of mass flow boundaries in continuous twin-screw granulation. Chimia (Aarau). 2016;70(9):604–609.
  • Thompson MR. Twin screw granulation - review of current progress. Drug Dev Ind Pharm. 2015;41(8):1223–1231.
  • Maniruzzaman M, Nair A, Renault M, et al. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug. Int J Pharm. 2015;496(1):52–62.
  • Maniruzzaman M, Nair A, Scoutaris N, et al. One-step continuous extrusion process for the manufacturing of solid dispersions. Int J Pharm. 2015;496(1):42–51.
  • Patil H, Tiwari RV, Upadhye SB, et al. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Int J Pharm. 2015 Dec 30;496(1):33–41.
  • Keen JM, Foley CJ, Hughey JR, et al. Continuous twin screw melt granulation of glyceryl behenate: development of controlled release tramadol hydrochloride tablets for improved safety. Int J Pharm. 2015 Jun 20;487(1–2):72–80.
  • Verstraete G, Mertens P, Grymonpre W, et al. A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices. Int J Pharm. 2016 Nov 20;513(1–2):602–611.
  • Monteyne T, Adriaensens P, Brouckaert D, et al. Stearic acid and high molecular weight PEO as matrix for the highly water soluble metoprolol tartrate in continuous twin-screw melt granulation. Int J Pharm. 2016;512(1):158–167.
  • Batra A, Desai D, Serajuddin ATM. Investigating the use of polymeric binders in twin screw melt granulation process for improving compactibility of drugs. J Pharm Sci. 2017 Jan;106(1):140–150.
  • Lakshman JP, Kowalski J, Vasanthavada M, et al. Application of melt granulation technology to enhance tabletting properties of poorly compactible high-dose drugs. J Pharm Sci. 2011 Apr;100(4):1553–1565.
  • Vervaet C, Remon JP. Continuous granulation in the pharmaceutical industry. Chem Eng Sci. 2005;60(14):3949–3957.
  • Malkowska S, Khan K, Lentle R, et al. Effect of re-compression on the properties of tablets prepared by moist granulation. Drug Dev Ind Pharm. 1983;9(3):349–361.
  • Maniruzzaman M, Ross SA, Dey T, et al. A quality by design (QbD) twin-Screw extrusion wet granulation approach for processing water insoluble drugs. Int J Pharm. 2017 Jun 30;526(1–2):496–505.
  • Kallakunta VR, Patil H, Tiwari R, et al. Exploratory studies in heat-assisted continuous twin-screw dry granulation: A novel alternative technique to conventional dry granulation. Int J Pharm. 2019 Jan;30(555):380–393.
  • Upadhye SB, Ph Ronald SVR, Repka MA, et al. Twin-screw dry granulation for producing solid formulations. Google Patents; 2017.
  • Liu Y, Thompson M, O’Donnell K. Impact of non-binder ingredients and molecular weight of polymer binders on heat assisted twin screw dry granulation. Int J Pharm. 2018;536(1):336–344.
  • Majumder M, Rajabnezhad S, Nokhodchi A, et al. Chemico-calorimetric analysis of amorphous granules manufactured via continuous granulation process. In: Drug delivery and translational research. 2018;8(6):1658–1669.
  • Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’drug delivery systems. Eur J Pharm Sci. 2000;11:S93–S98.
  • Kallakunta VR, Bandari S, Jukanti R, et al. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technol. 2012;221:375–382.
  • Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20–42.
  • Bhagurkar AM, Repka MA, Murthy SN. A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology. J Pharm Sci. 2017;106(4):1085–1091.
  • Pawar J, Narkhede R, Amin P, et al. Design and evaluation of topical diclofenac sodium gel using hot melt extrusion technology as a continuous manufacturing process with Kolliphor® P407. AAPS PharmSciTech. 2017;18(6):2303–2315.
  • Mendonsa NS, Murthy SN, Hashemnejad SM, et al. Development of poloxamer gel formulations via hot-melt extrusion technology. Int J Pharm. 2018;537(1–2):122–131.
  • Bagde A, Patel K, Kutlehria S, et al. Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength. In: Drug delivery and translational research. 2019. p. 1–12.
  • Quintavalle U, Voinovich D, Perissutti B, et al. Theoretical and experimental characterization of stearic acid-based sustained release devices obtained by hot melt co-extrusion. J Drug Delivery Sci Technol. 2007;17(6):415–420.
  • Quintavalle U, Voinovich D, Perissutti B, et al. Preparation of sustained release co-extrudates by hot-melt extrusion and mathematical modelling of in vitro/in vivo drug release profiles. Eur J Pharm Sci. 2008;33(3):282–293.
  • Dierickx L, Saerens L, Almeida A, et al. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices. Eur J Pharm Biopharm. 2012;81(3):683–689.
  • Dierickx L, Remon JP, Vervaet C. Co-extrusion as manufacturing technique for multilayer mini-matrices with dual drug release. Eur J Pharm Biopharm. 2013;85(3):1157–1163.
  • Dierickx L, Van Snick B, Monteyne T, et al. Co-extruded solid solutions as immediate release fixed-dose combinations. Eur J Pharm Biopharm. 2014;88(2):502–509.
  • Laukamp EJ, Vynckier A-K, Voorspoels J, et al. Development of sustained and dual drug release co-extrusion formulations for individual dosing. Eur J Pharm Biopharm. 2015;89:357–364.
  • Wening K, Breitkreutz J. Novel delivery device for monolithical solid oral dosage forms for personalized medicine. Int J Pharm. 2010;395(1–2):174–181.
  • Wening K, Laukamp EJ, Thommes M, et al. Individual oral therapy with immediate release and effervescent formulations delivered by the solid dosage pen. J Pers Med. 2012;2(4):217–231.
  • Jamróz W, Kurek M, Czech A, et al. 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusion. Eur J Pharm Biopharm. 2018;131:44–47.
  • Vynckier AK, Dierickx L, Voorspoels J, et al. Hot melt co-extrusion: requirements, challenges and opportunities for pharmaceutical applications. J Pharm Pharmacol. 2014;66(2):167–179.
  • Vynckier A-K, De Beer M, Monteyne T, et al. Enteric protection of naproxen in a fixed-dose combination product produced by hot-melt co-extrusion. Int J Pharm. 2015;491(1–2):243–249.
  • Hasa D, Perissutti B, Grassi M, et al. Melt extruded helical waxy matrices as a new sustained drug delivery system. Eur J Pharm Biopharm. 2011;79(3):592–600.
  • Van Laarhoven J, Kruft M, Vromans H. Effect of supersaturation and crystallization phenomena on the release properties of a controlled release device based on EVA copolymer. J Control Release. 2002;82(2–3):309–317.
  • Yang R, Wang Y, Zheng X, et al. Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets. Drug Dev Ind Pharm. 2008;34(1):83–89.
  • Gately NM, Kennedy JE. The development of a melt-extruded shellac carrier for the targeted delivery of probiotics to the colon. Pharmaceutics. 2017;9(4):38.
  • Balogh A, Farkas B, Domokos A, et al. Controlled-release solid dispersions of Eudragit® FS 100 and poorly soluble spironolactone prepared by electrospinning and melt extrusion. Eur Polym J. 2017;95:406–417.
  • Simons FJ, Wagner KG. Modeling, design and manufacture of innovative floating gastroretentive drug delivery systems based on hot-melt extruded tubes. Eur J Pharm Biopharm. 2019;137:196–208.
  • Zhang F. Melt-extruded Eudragit® FS-based granules for colonic drug delivery. AAPS PharmSciTech. 2016;17(1):56–67.
  • Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain®. 2013;154(11):2287–2296.
  • Maincent J, Zhang F. Recent advances in abuse-deterrent technologies for the delivery of opioids. Int J Pharm. 2016;510(1):57–72.
  • Gasior M, Bond M, Malamut R. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgrad Med. 2016;128(1):85–96.
  • Pon D, Awuah K, Curi D, et al. Combating an epidemic of prescription opioid abuse. Cda J. 2015;43:11.
  • Stanos SP, Bruckenthal P, Barkin RL, editors Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clinic Proceedings. 2012;87(7):683–694.
  • [cited 2019 Jan 18]. Available from: https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/default.htm
  • Baronsky-Probst J, Möltgen C-V, Kessler W, et al. Process design and control of a twin screw hot melt extrusion for continuous pharmaceutical tamper-resistant tablet production. Eur J Pharm Sci. 2016;87:14–21.
  • Jedinger N, Schrank S, Fischer JM, et al. Development of an abuse-and alcohol-resistant formulation based on hot-melt extrusion and film coating. AAPS PharmSciTech. 2016;17(1):68–77.
  • Nukala PK, Palekar S, Patki M, et al. Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction. AAPS PharmSciTech. 2019;20(2):80.
  • Qi S, Craig DQ. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: the inclusion of hydrophilic additives to develop moisture-activated release systems. Int J Pharm. 2016;514(1):270–281.
  • Crawford DE, Miskimmin CK, Albadarin AB, et al. Organic synthesis by Twin Screw Extrusion (TSE): continuous, scalable and solvent-free. Green Chem. 2017;19(6):1507–1518.
  • Ditzinger F, Scherer U, SchöNenberger M, et al. Modified polymer matrix in pharmaceutical hot melt extrusion by molecular interactions with a carboxylic coformer. Mol Pharm. 2018;16(1):141–150.
  • Parikh T, Serajuddin AT. Development of fast-dissolving amorphous solid dispersion of itraconazole by melt extrusion of its mixture with weak organic carboxylic acid and polymer. Pharm Res. 2018;35:1–10.
  • Nukala PK, Palekar S, Solanki N, et al. Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms. J 3D Print Med. 2019;3(1).
  • Saviano M, Aquino RP, Del Gaudio P, et al. Poly (vinyl alcohol) 3D printed tablets: the effect of polymer particle size on drug loading and process efficiency. Int J Pharm. 2019;561:1–8.
  • Ilyés K, Kovács NK, Balogh A, et al. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation. Eur J Pharm Sci. 2019;129:110–123.
  • Shi N-Q, Wang S-R, Zhang Y, et al. Hot melt extrusion technology for improved dissolution, solubility and “spring-parachute” processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: profiles and mechanisms. Eur J Pharm Sci. 2019;130:78–90.
  • Ma X, Huang S, Lowinger MB, et al. Influence of mechanical and thermal energy on nifedipine amorphous solid dispersions prepared by hot melt extrusion: preparation and physical stability. Int J Pharm. 2019;561:324–334.
  • Dhumal RS, Kelly AL, York P, et al. Cocrystalization and simultaneous agglomeration using hot melt extrusion. Pharm Res. 2010;27(12):2725–2733.
  • Daurio D, Medina C, Saw R, et al. Application of twin screw extrusion in the manufacture of cocrystals, part I: four case studies. Pharmaceutics. 2011;3(3):582–600.
  • Kelly AL, Gough T, Dhumal RS, et al. Monitoring ibuprofen–nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool. Int J Pharm. 2012;426(1–2):15–20.
  • Liu X, Lu M, Guo Z, et al. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res. 2012;29(3):806–817.
  • Moradiya H, Islam MT, Woollam GR, et al. Continuous cocrystallization for dissolution rate optimization of a poorly water-soluble drug. Cryst Growth Des. 2013;14(1):189–198.
  • Daurio D, Nagapudi K, Li L, et al. Application of twin screw extrusion to the manufacture of cocrystals: scale-up of AMG 517–sorbic acid cocrystal production. Faraday Discuss. 2014;170:235–249.
  • Moradiya HG, Islam MT, Halsey S, et al. Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing. CrystEngComm. 2014;16(17):3573–3583.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.